European Pharmaceutical Review
JANUARY 9, 2024
Adding these developments with the addition of connected IoT devices, supply chain restructuring and consideration for our code of ethics will give us a glimpse at how pharmaceutical production will look in future. 2016; 85(4):2048-2050. 2016; 12(7):878. Eur J Radiol. Jamshidi N, Eslami M. J Am Coll Radiol. Mol Syst Biol.
Pharmaceutical Representative Training
MARCH 17, 2025
One of the most difficult parts of introducing a pharmaceutical product is the regulatory environment. There are less opportunities for face-to-face interaction due to time restrictions and an increasing reliance on virtual consultations. Nowadays, a lot of healthcare professionals prefer digital updates that are timely and pertinent.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 27, 2022
The association also said that the UK’s exports and imports of pharmaceutical products were notably lower than those of the majority of comparators. These values have seen a year-on-year decline since 2016 for exports and 2015 for imports, in contrast with a general upward trend seen in most comparator countries, said the ABPI.
Pharmaceutical Technology
NOVEMBER 30, 2022
A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT. Time for change. Free Webinar.
European Pharmaceutical Review
JUNE 24, 2022
This means numerous key aspects of how pharmaceuticals are regulated in the EU could be affected, from costing and reimbursement to intellectual property rights, incentives and more. Stakeholders in the EU often use the risk-adjusted Net Present Value (rNPV) investment model to determine whether to invest in a pharmaceutical product.
PharmaKinnex
AUGUST 23, 2022
The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. In order to succeed and grow, pharmaceutical products and service providers must remain flexible and up-to-date with modern marketing and technology that supports, educates, and comforts their consumers.
European Pharmaceutical Review
OCTOBER 19, 2022
Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 26 April, 2016.
Expert insights. Personalized for you.
122 
Let's personalize your content